These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21250846)

  • 1. Effect of sample collection tubing type used in a clinical study on quantitation of pharmaceutical compounds in CSF by LC-MS/MS.
    Wagdy AM; Kim JC; Kim GE; Wu H; El-Shourbagy T
    Bioanalysis; 2011 Jan; 3(2):167-79. PubMed ID: 21250846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a surrogate matrix for cerebral spinal fluid for liquid chromatography/mass spectrometry based analytical methods.
    Hooshfar S; Basiri B; Bartlett MG
    Rapid Commun Mass Spectrom; 2016 Apr; 30(7):854-8. PubMed ID: 26969926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
    Wu ST; Ouyang Z; Olah TV; Jemal M
    Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens.
    Liu HC; Liu RH; Ho HO; Lin DL
    Anal Chem; 2009 Nov; 81(21):9002-11. PubMed ID: 19788251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acetone as organic modifier in SPE for bioanalytical quantitative LC-MS/MS.
    MacNeill R; Evans E
    Bioanalysis; 2011 Feb; 3(3):291-300. PubMed ID: 21320050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry.
    Madureira TV; Barreiro JC; Rocha MJ; Cass QB; Tiritan ME
    J Chromatogr A; 2009 Oct; 1216(42):7033-42. PubMed ID: 19748099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
    Jian W; Edom RW; Xu Y; Gallagher J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
    Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
    J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater.
    Bueno MJ; Agüera A; Gómez MJ; Hernando MD; García-Reyes JF; Fernandez-Alba AR
    Anal Chem; 2007 Dec; 79(24):9372-84. PubMed ID: 18001124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
    Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
    Hsieh Y
    Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS.
    Liu K; Zhong D; Chen X
    Bioanalysis; 2009 Jun; 1(3):561-76. PubMed ID: 21083153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking.
    Young BL; Cooks RG; Madden MC; Bair M; Jia J; Aubry AF; Miller SA
    J Pharm Biomed Anal; 2007 Apr; 43(5):1602-8. PubMed ID: 17298872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improvement of a multi-target screening analysis for drugs using a QTRAP liquid chromatography/tandem mass spectrometry system].
    Miyagi H; Kajiwara M; Onishi H; Yamaguchi Y; Watanabe T
    Rinsho Byori; 2007 Apr; 55(4):309-18. PubMed ID: 17511260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fast and simple assay for busulfan in serum or plasma by liquid chromatography-tandem mass spectrometry using turbulent flow online extraction technology.
    Bunch DR; Heideloff C; Ritchie JC; Wang S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3255-8. PubMed ID: 21030324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
    Tong W; Chowdhury SK; Su AD; Alton KB
    Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.